Agenda (pdf)
The conference agenda included general sessions and focused workshops on topics
of interest to the high-risk and hereditary cancer community.
FORCE's second annual symposium on hereditary breast and ovarian cancer was held May 18-19, 2007 at the Hyatt Regency in Tampa, Florida. We welcomed 370 attendees from 36 states, seven countries, and four continents. All attendess were people concerned about hereditary cancer: cancer survivors, high-risk individuals, those with a BRCA mutation or family history of cancer, and health care providers who treat high-risk patients.
The 2007 conference was a collaborative effort of FORCE: Facing Our Risk of Cancer Empowered, the H. Lee Moffitt Cancer Center and Research Institute, and the University of South Florida.
A free webcast from the conference is available (disclaimer/registration required).

Agenda (pdf)
The conference agenda included general sessions and focused workshops on
topics of interest to the high-risk and hereditary cancer community.
Financial supporters
The Joining FORCEs conference was made possible through grants and financial
support from generous donors. more...
Linda Pedraza Memorial Scholarship Fund
FORCE was able to provide scholarships for 15 people to attend the Joining
FORCEs conference through generous donations to the Linda Pedraza Memorial
Scholarship Fund. Read more about the fund and how you can apply for a
scholarship or donate to help others attend future FORCE conferences.
Our conference proceedings and tote are available for $20 each through the FORCE shop.
FORCE's first annual symposium on hereditary breast and ovarian cancer was held February 10-11, 2006 at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida. More than 200 people from 28 states, 5 countries and 3 continents attended our conference on hereditary breast and ovarian cancer.
The conference objective was to provide a balanced mix of information, networking, support, and fun. With this event, we made history—the first national conference devoted to hereditary breast and ovarian cancer.
Our stellar cast of speakers included respected physicians, international researchers, and women who graciously shared experiences and insights about living with hereditary cancer or high-risk status.
Feedback after the conference was positive: 92 percent of respondents rated it “outstanding” or “excellent;” 100 percent of respondents felt the conference met or exceeded their expectations.
You can view our 2006 brochure (pdf) and agenda (pdf).